676 related articles for article (PubMed ID: 28838196)
1. Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future.
Patel M; Cochi S
J Infect Dis; 2017 Jul; 216(suppl_1):S1-S8. PubMed ID: 28838196
[TBL] [Abstract][Full Text] [Related]
2. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
Orenstein WA;
Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
[TBL] [Abstract][Full Text] [Related]
3. Communications, Immunization, and Polio Vaccines: Lessons From a Global Perspective on Generating Political Will, Informing Decision-Making and Planning, and Engaging Local Support.
Menning L; Garg G; Pokharel D; Thrush E; Farrell M; Kodio FK; Veira CL; Wanyoike S; Malik S; Patel M; Rosenbauer O
J Infect Dis; 2017 Jul; 216(suppl_1):S24-S32. PubMed ID: 28838189
[TBL] [Abstract][Full Text] [Related]
4. Polio Endgame: Lessons Learned From the Immunization Systems Management Group.
Zipursky S; Vandelaer J; Brooks A; Dietz V; Kachra T; Farrell M; Ottosen A; Sever JL; Zaffran MJ
J Infect Dis; 2017 Jul; 216(suppl_1):S9-S14. PubMed ID: 28838174
[TBL] [Abstract][Full Text] [Related]
5. Polio endgame: the global introduction of inactivated polio vaccine.
Patel M; Zipursky S; Orenstein W; Garon J; Zaffran M
Expert Rev Vaccines; 2015 May; 14(5):749-62. PubMed ID: 25597843
[TBL] [Abstract][Full Text] [Related]
6. The polio endgame: rationale behind the change in immunisation.
Garon J; Patel M
Arch Dis Child; 2017 Apr; 102(4):362-365. PubMed ID: 28096107
[TBL] [Abstract][Full Text] [Related]
7. Implementing the Synchronized Global Switch from Trivalent to Bivalent Oral Polio Vaccines-Lessons Learned From the Global Perspective.
Ramirez Gonzalez A; Farrell M; Menning L; Garon J; Everts H; Hampton LM; Dolan SB; Shendale S; Wanyoike S; Veira CL; Châtellier GMD; Kurji F; Rubin J; Boualam L; Chang Blanc D; Patel M
J Infect Dis; 2017 Jul; 216(suppl_1):S183-S192. PubMed ID: 28838179
[TBL] [Abstract][Full Text] [Related]
8. Polio Eradication and Endgame Plan - Victory within Grasp.
Patel M; Menning L; Bhatnagar P
Indian Pediatr; 2016 Aug; 53 Suppl 1():S28-S32. PubMed ID: 27771636
[TBL] [Abstract][Full Text] [Related]
9. The polio endgame.
Minor P
Hum Vaccin Immunother; 2014; 10(7):2106-8. PubMed ID: 25608050
[TBL] [Abstract][Full Text] [Related]
10. Lessons Learned From Managing the Planning and Implementation of Inactivated Polio Vaccine Introduction in Support of the Polio Endgame.
Zipursky S; Patel M; Farrell M; Gonzalez AR; Kachra T; Folly Y; Kurji F; Veira CL; Wootton E; Hampton LM
J Infect Dis; 2017 Jul; 216(suppl_1):S15-S23. PubMed ID: 28838203
[TBL] [Abstract][Full Text] [Related]
11. [The role of Sabin inactivated poliovirus vaccine in the final phase of global polio eradication].
Dong SZ; Zhu WB
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1032-1035. PubMed ID: 28057104
[TBL] [Abstract][Full Text] [Related]
12. Global Polio Eradication,The Journey So Far.
Thacker N; Yewale VN; Pathak A
Indian Pediatr; 2016 Aug; 53 Suppl 1():S61-S64. PubMed ID: 27771642
[TBL] [Abstract][Full Text] [Related]
13. Introduction of Inactivated Poliovirus Vaccine in National Immunization Program and Polio Endgame Strategy.
; Vashishtha VM; Choudhary J; Yadav S; Unni JC; Jog P; Kamath SS; Sachdeva A; Srirampur S; Prajapati B; Parekh BJ
Indian Pediatr; 2016 Aug; 53 Suppl 1():S65-S69. PubMed ID: 27133231
[TBL] [Abstract][Full Text] [Related]
14. Polio endgame: Lessons for the global rotavirus vaccination program.
Jiang B; Patel M; Glass RI
Vaccine; 2019 May; 37(23):3040-3049. PubMed ID: 31027927
[TBL] [Abstract][Full Text] [Related]
15. Polio endgame: the global switch from tOPV to bOPV.
Garon J; Seib K; Orenstein WA; Ramirez Gonzalez A; Chang Blanc D; Zaffran M; Patel M
Expert Rev Vaccines; 2016 Jun; 15(6):693-708. PubMed ID: 26751187
[TBL] [Abstract][Full Text] [Related]
16. National introduction of fractional-dose inactivated polio vaccine in Sri Lanka following the global "switch".
Gamage D; Ginige S; Palihawadana P
WHO South East Asia J Public Health; 2018 Sep; 7(2):79-83. PubMed ID: 30136665
[TBL] [Abstract][Full Text] [Related]
17. Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010-2014.
Liu Y; Wang J; Liu S; Du J; Wang L; Gu W; Xu Y; Zuo S; Xu E; An Z
Vaccine; 2017 Mar; 35(9):1281-1286. PubMed ID: 28161421
[TBL] [Abstract][Full Text] [Related]
18. Logistical challenges and assumptions for modeling the failure of global cessation of oral poliovirus vaccine (OPV).
Thompson KM; Kalkowska DA
Expert Rev Vaccines; 2019 Jul; 18(7):725-736. PubMed ID: 31248293
[No Abstract] [Full Text] [Related]
19. Exceptional Financial Support for Introduction of Inactivated Polio Vaccine in Middle-Income Countries.
Blankenhorn AL; Cernuschi T; Zaffran MJ
J Infect Dis; 2017 Jul; 216(suppl_1):S52-S56. PubMed ID: 28838169
[TBL] [Abstract][Full Text] [Related]
20. Introduction of Inactivated Polio Vaccine, Withdrawal of Type 2 Oral Polio Vaccine, and Routine Immunization Strengthening in the Eastern Mediterranean Region.
Fahmy K; Hampton LM; Langar H; Patel M; Mir T; Soloman C; Hasman A; Yusuf N; Teleb N
J Infect Dis; 2017 Jul; 216(suppl_1):S86-S93. PubMed ID: 28838199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
